Bullfrog AI is a technology-enabled drug development firm. With the goal of being “the future of AI-assisted drug development”, BullFrog aims to use machine learning in medical breakthroughs. In the right hands, artificial intelligence could save lives. Here’s how one company aims to do just that.
What is Bullfrog AI?
Bullfrog AI Holdings Inc is a ‘next-generation’ drug discovery firm. In other words, it uses artificial intelligence to take the guesswork out of a very time-consuming research process, thereby helping to accelerate our knowledge of medicine.
In its own words, the generative AI firm creates and analyzes “networks of biological, clinical, and real-world data spanning from early discovery to late-stage clinical trials”. It does this using a proprietary platform called bfLEAP, which “leverages the power of AI and machine learning to digest and analyze large sets of disparate data.” In doing so, it reveals insights that “may lead to identifying new potential therapeutic targets, indication expansion opportunities for existing products, and drug rescuing or repurposing.”
Essential AI Tools
Content Guardian – AI Content Checker – One-click, Eight Checks
Jasper AI
WordAI
Copy.ai
Writesonic
Could AI-assisted drug development be a thriving future for humankind?
Many pharmaceutical firms are already using artificial intelligence, which has proven effective in the field of medical research.
Three years ago, the United States National Library of Medicine published a study that details how “the use of artificial intelligence (AI) has been increasing in … the pharmaceutical industry”. Last year, scientists from the Agency for Science, Technology and Research (A*STAR) Genome Institute of Singapore (GIS) announced an RNA sequencing tool named Bambu. In this case, the tool can tell us more about our own DNA. Most recently, Google DeepMind reportedly catapulted materials science “800 years into the future“. In each case, artificial intelligence has accelerated a painstakingly time-consuming process in the service of improving our lives as humans.
FAQ – Who is the owner of Bullfrog AI?
BullFrog AI Holdings, Inc. is a publicly held US business with no parent company. It is led by CEO Vin Singh. The senior leadership team includes both a VP of AI, Enrique García-Rivera, PhD, as well as a VP of Drug Development, Thomas Hazel, PhD.
Who is the CEO of BigBear Holdings?
BigBear Holdings is a separate corporation, which “provides decision intelligence solutions and is trusted by leaders in government & defense, manufacturing & warehouse operations, and healthcare & life sciences.” CEO Mandy Long leads the senior leadership team. This follows an award-winning career, leading product and strategy for IBM Watson in various VP roles.
